Keyword: Corden Pharma


CordenPharma Lifts xRNA Capability in Italy

13.06.2022 -

German CDMO CordenPharma, a specialist in Active Pharmaceutical Ingredients (APIs), excipients, drug products and packaging services (APIs), is investing more than €10...


Astorg to Acquire CordenPharma from ICIG

04.05.2022 -

Private equity investor Astorg has signed a binding agreement with International Chemical Investors Group (ICIG) to acquire Plankstadt, Germany-based CDMO CordenPharma...


CordenPharma Lifts Lipids Capacity in France

02.03.2022 -

Full-service CDMO CordenPharma is making a major investment to increase lipid manufacturing capacity at its CordenPharma Chenôve facility near Dijon, France. The project...


CordenPharma Sale Rumors Take Firm Shape

19.01.2022 -

Rumors that German pharmaceutical producer CordenPharma is up for sale have resurfaced following fresh reports that the company’s owner, International Chemical Investors...


Wacker and CordenPharma in Lipid Nanoparticles Partnership

16.12.2021 -

German chemical company Wacker and compatriot CDMO CordenPharma have agreed to jointly develop know-how and processes for manufacturing lipid nanoparticles (LNP) to meet...


CordenPharma Creates Flow Chemistry Centre of Excellence at Chenôve

03.11.2021 -

Contract development and manufacturing organization (CDMO) CordenPharma has announced the completion of a Phase 1 strategic investment to create a Flow Chemistry Centre...


CordenPharma Expands non-GMP Peptides

20.11.2020 -

Reacting to recent growth in European domestic demand, Luxembourg-headquartered CordenPharma is expanding capacity for non-GMP peptides at its center of excellence for...

Markets & Companies

Expert Interview: Michael Quirmbach, CordenPharma

16.10.2020 -

So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has...